Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Supplementation with Neoadjuvant Immunotherapy in Gastric Cancer
NCT07050524Phase 2Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Pathologic Complete Response. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07050524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07050524.